Literature DB >> 26724202

Synthetic antibiofilm peptides.

César de la Fuente-Núñez1, Marlon Henrique Cardoso2, Elizabete de Souza Cândido3, Octavio Luiz Franco4, Robert E W Hancock5.   

Abstract

Bacteria predominantly exist as multicellular aggregates known as biofilms that are associated with at least two thirds of all infections and exhibit increased adaptive resistance to conventional antibiotic therapies. Therefore, biofilms are major contributors to the global health problem of antibiotic resistance, and novel approaches to counter them are urgently needed. Small molecules of the innate immune system called host defense peptides (HDPs) have emerged as promising templates for the design of potent, broad-spectrum antibiofilm agents. Here, we review recent developments in the new field of synthetic antibiofilm peptides, including mechanistic insights, synergistic interactions with available antibiotics, and their potential as novel antimicrobials against persistent infections caused by biofilms. This article is part of a Special Issue entitled: Antimicrobial peptides edited by Karl Lohner and Kai Hilpert.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Biofilms; Biomaterials; Persistent infections; Synergy; Synthetic peptides

Mesh:

Substances:

Year:  2015        PMID: 26724202      PMCID: PMC4809770          DOI: 10.1016/j.bbamem.2015.12.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  67 in total

Review 1.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

2.  High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides.

Authors:  Evan F Haney; Sarah C Mansour; Ashley L Hilchie; César de la Fuente-Núñez; Robert E W Hancock
Journal:  Peptides       Date:  2015-03-31       Impact factor: 3.750

Review 3.  (p)ppGpp: still magical?

Authors:  Katarzyna Potrykus; Michael Cashel
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

Review 4.  Persister cells in biofilm associated infections.

Authors:  Brian P Conlon; Sarah E Rowe; Kim Lewis
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 5.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

Review 6.  Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.

Authors:  Lesley Uttley; Sue Harnan; Anna Cantrell; Chris Taylor; Martin Walshaw; Keith Brownlee; Paul Tappenden
Journal:  Eur Respir Rev       Date:  2013-12

7.  Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium.

Authors:  Mehdi Kazemzadeh-Narbat; Shahryar Noordin; Bassam A Masri; Donald S Garbuz; Clive P Duncan; Robert E W Hancock; Rizhi Wang
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2012-05-07       Impact factor: 3.368

Review 8.  The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver.

Authors:  Douglas Roberto Monteiro; Luiz Fernando Gorup; Aline Satie Takamiya; Adhemar Colla Ruvollo-Filho; Emerson Rodrigues de Camargo; Debora Barros Barbosa
Journal:  Int J Antimicrob Agents       Date:  2009-03-31       Impact factor: 5.283

9.  Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide.

Authors:  Zhejun Wang; Cesar de la Fuente-Núñez; Ya Shen; Markus Haapasalo; Robert E W Hancock
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

10.  Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus.

Authors:  Ramamourthy Gopal; Jun Ho Lee; Young Gwon Kim; Myeong-Sun Kim; Chang Ho Seo; Yoonkyung Park
Journal:  Mar Drugs       Date:  2013-05-28       Impact factor: 5.118

View more
  54 in total

1.  Antibiofilm peptides as a promising strategy: comparative research.

Authors:  Jing Li; Dongru Chen; Huancai Lin
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-21       Impact factor: 4.813

Review 2.  Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.

Authors:  Cesar de la Fuente-Nunez; Marcelo Dt Torres; Francisco Jm Mojica; Timothy K Lu
Journal:  Curr Opin Microbiol       Date:  2017-06-14       Impact factor: 7.934

Review 3.  Antimicrobial host defence peptides: functions and clinical potential.

Authors:  Neeloffer Mookherjee; Marilyn A Anderson; Henk P Haagsman; Donald J Davidson
Journal:  Nat Rev Drug Discov       Date:  2020-02-27       Impact factor: 84.694

Review 4.  Antimicrobial Peptides: Mechanisms of Action and Resistance.

Authors:  B Bechinger; S-U Gorr
Journal:  J Dent Res       Date:  2016-11-25       Impact factor: 6.116

Review 5.  The Impact of Incorporating Antimicrobials into Implant Surfaces.

Authors:  N J Hickok; I M Shapiro; A F Chen
Journal:  J Dent Res       Date:  2017-09-18       Impact factor: 6.116

6.  Two novel synthetic peptides inhibit quorum sensing-dependent biofilm formation and some virulence factors in Pseudomonas aeruginosa PAO1.

Authors:  Mostafa N Taha; Amal E Saafan; A Ahmedy; Eman El Gebaly; Ahmed S Khairalla
Journal:  J Microbiol       Date:  2019-06-27       Impact factor: 3.422

7.  Clinical potential of engineered cationic antimicrobial peptides against drug resistant biofilms.

Authors:  Jeffrey A Melvin; Ronald C Montelaro; Jennifer M Bomberger
Journal:  Expert Rev Anti Infect Ther       Date:  2016-09-22       Impact factor: 5.091

8.  Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.

Authors:  Pavel M Kopeikin; Maria S Zharkova; Alexander A Kolobov; Maria P Smirnova; Maria S Sukhareva; Ekaterina S Umnyakova; Vladimir N Kokryakov; Dmitriy S Orlov; Boris L Milman; Sergey V Balandin; Pavel V Panteleev; Tatiana V Ovchinnikova; Aleksey S Komlev; Alessandro Tossi; Olga V Shamova
Journal:  Front Cell Infect Microbiol       Date:  2020-10-19       Impact factor: 5.293

9.  A coarse-grained approach to studying the interactions of the antimicrobial peptides aurein 1.2 and maculatin 1.1 with POPG/POPE lipid mixtures.

Authors:  G E Balatti; M F Martini; M Pickholz
Journal:  J Mol Model       Date:  2018-07-17       Impact factor: 1.810

10.  Challenges and Opportunities of Nontraditional Approaches to Treating Bacterial Infections.

Authors:  Brian N Tse; Amesh A Adalja; Christopher Houchens; Joseph Larsen; Thomas V Inglesby; Richard Hatchett
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.